Search Results - George D. Yancopoulos

George Yancopoulos

George D. Yancopoulos (born 1959) is a Greek-American biomedical scientist who is the co-founder, president and chief scientific officer of Regeneron Pharmaceuticals.

Yancopoulos is an elected member of the National Academy of Sciences, a fellow of the American Academy of Arts and Sciences (AAAS), and the holder of more than 100 patents. He is a principal inventor and developer of Regeneron's ten FDA-approved or -authorized treatments, as well as of Regeneron's foundational technologies for target and drug development, such as its proprietary TRAP technology, and the VelociGene and VelocImmune antibody technologies. Provided by Wikipedia
  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    Cover Image

    Interleukin-19 Is a Negative Regulator of Innate Immunity and Critical for Colonic Protection by Yasu-Taka Azuma, Yukiko Matsuo, Hidemitsu Nakajima, George D. Yancopoulos, David M. Valenzuela, Andrew J. Murphy, Margaret Karow, Tadayoshi Takeuchi

    Published 2011
    Connect to this object online.
    Book

    Save to List
    Saved in:

Search Tools: